pfaas schreef op 4 juni 2018 11:08:
De update van de financial guidance leest als een raadsel dat ik nog niet heb kunnen oplossen.
Maar de druk op de EBITDA lijkt inderdaad mee te vallen en ook de cash-out. Slim gedaan met een earnout regeling vanaf 2021. Maar hoe Total-Corbion JV er in is verwerkt is mij niet duidelijk.
All Ingredient Solutions guidance unchanged
Corbion organic net sales growth in 2018-2021 period of 3-6% per annum
(was: net sales including proportionately consolidated joint ventures growth of 3-6% per annum)
Innovation Platforms net sales growth >20% per annum
(was: 10-30% per annum including proportionately consolidated joint ventures)
Innovation Platforms EBITDA approaching break-even in 2021
(was: EBITDA including proportionately consolidated joint ventures approaching break-even in 2021)
Innovation Platforms 2018 EBITDA loss expected between € -40 million and € -35 million; 2019 EBITDA loss not expected to exceed € -35 million
(was: maximum EBITDA including proportionately consolidated joint ventures loss is not expected to exceed € -35 million per annum for the years 2018 and 2019)
Innovation Platforms recurring capex of € 20-30 million (was: recurring capex of € 20-30 million including proportional joint venture investments)